性別適合手術の世界市場：評価 - 性別移行別、手術タイプ別、地域別、機会、予測、2017～2031年

世界の性別適合手術（SRS）の市場規模は、2024～2031年の予測期間中にCAGR 11.8％で拡大し、2023年の7億5,912万米ドルから2031年には18億5,287万米ドルに達すると予測されています。顔の女性化手術、生殖器の再建（膣形成術、陰茎形成術、睾丸摘出術）、胸部手術（乳房切除術）、その他の性別適合手術を含むこれらの手術は、専門の外科医によって実施されます。トランスジェンダーであることを自認する人や、性別不適合であることを自認する人は、クリニックでこれらの手術を受けることができます。包括的なトランスジェンダーヘルスケアが含まれます。トランスジェンダー患者の包括的なニーズに応えるため、手術前後のケア、ホルモン療法、メンタルヘルスサポート、その他の医療サービスを提供しています。トランスジェンダーの受け入れ拡大と技術の進歩の両方が、市場の大幅な拡大に寄与しています。

SRSの需要は、性別違和の増加や性別確認手術を選ぶ人の増加といった要因によって牽引されています。しかし、手術費用の高さと社会的烙印が、世界の性別適合手術市場の抑制要因となっています。市場の将来は、持続的な技術革新、アクセシビリティの向上、性別適合医療を求めるトランスジェンダーへの包括的支援にかかっています。アクセスが制限されている地域では、性別適合手術をめぐる認識、教育、資源に大きな成長の余地があります。SRS手術の安全性と有効性は、手術手技と術後ケアの継続的な技術改善によってさらに向上し、より多くの人々がこのサービスを求めるようになるかもしれないです。さらに、ジェンダーを肯定する手術の選択肢を広げることを目的とした研究開発への資金提供は、トランスジェンダーの人々の要求に応える、より専門的で効率的な治療をもたらす可能性があります。例えば、NahariyaのGalilee Medical Centerは2023年7月、初めてジェンダーを肯定する手術を3件成功させ、大きなマイルストーンを達成したと発表しました。同様に、インドのデリーにあるRam Manohar Lohia（RML）病院は、2023年9月18日にトランスジェンダー専用の国内初の外来部門（OPD）を開設しました。

当レポートでは、世界の性別適合手術市場について調査し、市場概要とともに、性別移行別、手術タイプ別、地域別動向、および市場に参入する企業プロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の性別適合手術市場の展望、2017～2031年

• 市場規模・予測
• 性別移行別
• 手術タイプ別
• 地域別
• 企業別市場シェア（％）、2023年

第5章 世界の性別適合手術市場の展望、地域別（2017～2031年）

• 北米
• 欧州
• アジア太平洋
• 南米
• 中東・アフリカ

第6章 市場マッピング、2023年

第7章 マクロ環境・産業構造

• 需要供給分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 ケーススタディ

第12章 主要参入企業の展望

• Cedars-Sinai Medical Center
• Cleveland Clinic
• Icahn School of Medicine at Mount Sinai
• Moein Surgical Arts
• Transgender Surgery Institute
• Plastic Surgery Group of Rochester
• Regents of the University of Michigan
• CNY Cosmetic & Reconstructive Surgery
• Boston Medical Center
• Johns Hopkins University

第13章 戦略的提言

第14章 会社概要・免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 2. Global Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 3. Global Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 4. Global Sex Reassignment Surgery Market Share (%), By Region, 2017-2031F
• Figure 5. North America Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 6. North America Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 7. North America Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 8. North America Sex Reassignment Surgery Market Share (%), By Country, 2017-2031F
• Figure 9. United States Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 10. United States Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 11. United States Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 12. Canada Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 13. Canada Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 14. Canada Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 15. Mexico Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 16. Mexico Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 17. Mexico Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 18. Europe Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 19. Europe Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 20. Europe Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 21. Europe Sex Reassignment Surgery Market Share (%), By Country, 2017-2031F
• Figure 22. Germany Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 23. Germany Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 24. Germany Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 25. France Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 26. France Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 27. France Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 28. Italy Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 29. Italy Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 30. Italy Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 31. United Kingdom Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 32. United Kingdom Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 33. United Kingdom Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 34. Russia Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 35. Russia Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 36. Russia Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 37. Netherlands Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 38. Netherlands Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 39. Netherlands Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 40. Spain Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 41. Spain Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 42. Spain Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 43. Turkey Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 44. Turkey Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 45. Turkey Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 46. Poland Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 47. Poland Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 48. Poland Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 49. South America Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 50. South America Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 51. South America Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 52. South America Sex Reassignment Surgery Market Share (%), By Country, 2017-2031F
• Figure 53. Brazil Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 54. Brazil Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 55. Brazil Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 56. Argentina Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 57. Argentina Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 58. Argentina Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 59. Asia-Pacific Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 60. Asia-Pacific Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 61. Asia-Pacific Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 62. Asia-Pacific Sex Reassignment Surgery Market Share (%), By Country, 2017-2031F
• Figure 63. India Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 64. India Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 65. India Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 66. China Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 67. China Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 68. China Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 69. Japan Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 70. Japan Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 71. Japan Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 72. Australia Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 73. Australia Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 74. Australia Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 75. Vietnam Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 76. Vietnam Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 77. Vietnam Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 78. South Korea Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 79. South Korea Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 80. South Korea Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 81. Indonesia Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 82. Indonesia Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 83. Indonesia Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 84. Philippines Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 85. Philippines Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 86. Philippines Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 87. Middle East & Africa Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 88. Middle East & Africa Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 89. Middle East & Africa Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 90. Middle East & Africa Sex Reassignment Surgery Market Share (%), By Country, 2017-2031F
• Figure 91. Saudi Arabia Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 92. Saudi Arabia Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 93. Saudi Arabia Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 94. UAE Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 95. UAE Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 96. UAE Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 97. South Africa Sex Reassignment Surgery Market, By Value, In USD Million, 2017-2031F
• Figure 98. South Africa Sex Reassignment Surgery Market Share (%), By Gender Transition, 2017-2031F
• Figure 99. South Africa Sex Reassignment Surgery Market Share (%), By Surgery Type, 2017-2031F
• Figure 100. By Gender Transition Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 101. By Surgery Type Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 102. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

Global sex reassignment surgery market is projected to witness a CAGR of 11.8% during the forecast period 2024-2031, growing from USD 759.12 million in 2023 to USD 1852.87 million in 2031. Gender-affirming surgical procedures are the heart of the sex reassignment surgery (SRS) market, these operations, which might involve face feminization surgery, genital reconstruction (vaginoplasty, phalloplasty, orchiectomy), chest surgery (mastectomy), and other gender-confirming surgeries, are carried out by specialized surgeons. People who identify as transgender or who identify as gender non-conforming can have these operations from clinics. Comprehensive transgender healthcare services are included. To meet the comprehensive needs of transgender patients, it offers pre- and post-operative care, hormone therapy, mental health support, and other medical services. Both the growing acceptance of transgender people and advancements in technology have contributed to the market's significant expansion.

The demand for SRS is being driven by factors such as rising incidences of gender dysphoria and the increasing number of people opting for gender confirmation surgeries. The high cost of surgery and social stigma are, however, acting as a hindrance to the global sex reassignment market. The market's future is dependent on sustained innovation, increased accessibility, and all-encompassing assistance for transgender people looking for gender-affirming medical care. There is a great deal of room for growth in the awareness, education, and resources surrounding gender-affirming surgeries in areas where access is restricted. The safety and efficacy of SRS operations will be further improved by ongoing technological improvement in surgical techniques and post-operative care, which may encourage more people to seek these services. Additionally, funding for research and development aimed at expanding surgical choices that are gender-affirming can result in more specialized and efficient treatments that cater to the requirements of transgender people. For instance, the Galilee Medical Center in Nahariya announced in July 2023 that it accomplished a major milestone by performing three gender-affirming procedures successfully for the first time. Similarly, Ram Manohar Lohia (RML) Hospital, located in Delhi, India, opened the nation's first outpatient department (OPD) specifically for the transgender population on September 18, 2023.

Increasing Awareness and Gender Acceptance Lead to Market Expansion

One major reason propelling the growth of the sex reassignment surgery (SRS) industry is population awareness. Raising awareness has been greatly aided by transgender people's increased acceptance and visibility in the media, in public discussions, and in social movements. A growing number of people are considering SRS as a feasible option for integrating their physical look with their gender identity, which is also a result of well-known public figures and activists candidly sharing their transitions, which has helped demystify the procedure and lessen the stigma that goes around it. LGBTQ+ rights organizations' educational efforts and resources have also proven to be very helpful. These programs enlighten individuals about their options, rights, and the availability of SRS, resulting in increased understanding and acceptance. As more people become aware of the advantages and accessibility of SRS, demand will inevitably rise. By offering forums for exchanging insights and guidance, online communities and support groups help make information on SRS more approachable and less intimidating. A growing number of healthcare providers are knowledgeable about transgender health challenges because of activism and educational initiatives. The industry is expected to grow further as a result of the increased awareness among medical professionals, which improves patient care and increases SRS referrals.

Patients see increased support throughout their healthcare journey as medical professionals grow more skilled in discussing and recommending SRS. Additionally, in response to the demands and rights of their employees, employers and insurers are increasingly likely to incorporate SRS into their healthcare plans as awareness grows. Overall, the rising awareness among the population is breaking down barriers, fostering a supportive environment, and significantly contributing to the growth and expansion of the sex reassignment surgery market. For example, according to a new study, some 3 to 4 years ago, the number of people seeking gender-affirming surgeries-such as breast and chest operations or genital reconstruction-nearly tripled. The study followed over 48,000 patients who underwent surgeries at hospitals and same-day surgical centers between 2016 and 2020, using the most recent data available. According to a report published on JAMA Network Open, the number of patients undergoing these surgeries nearly tripled from 4,552 in 2016 to 13,011 in 2019 before significantly declining in 2020 due to the COVID-19 restrictions that delayed or stopped several sorts of non-emergency operations.

Growth in Market Due to Government's Support and Favorable Policies

The market for sex reassignment surgery (SRS) is growing due to government support and policies. One of the primary drivers is the increasing recognition and protection of transgender rights. Many countries are enacting laws that prohibit discrimination based on gender identity, thereby fostering a more inclusive environment. A larger range of people can undergo SRS and related therapies because of the healthcare coverage provisions found in these regulatory systems. For example, public health systems in Canada and some European countries have included SRS in their regular medical care packages that are insurance-covered. There has been a noticeable trend in the United States towards requiring insurance coverage for transgender healthcare, including SRS, through medical and private insurers. However, state-by-state variations exist in coverage. Furthermore, government-funded initiatives for education and awareness are assisting in reducing the stigma around the acceptance of transgenders in the society. These programs encourage more people to seek SRS and related services, which grows the market, by fostering awareness and acceptance. Research funds and financing for medical facilities to develop and innovate SRS techniques expand the market by offering more operations and better results.

A framework for secure and efficient SRS procedures is also provided by international guidelines and recommendations from groups like the World Health Organisation and the World Professional Association for Transgender Health, which are frequently backed by governments. By developing best practices and promoting international medical tourism, these guidelines aid in the standardization of care, enhancement of patient outcomes, and expansion of the worldwide market. Overall, supportive government policies and initiatives are pivotal in reducing barriers, enhancing accessibility, and promoting the growth of the sex reassignment surgery market globally. For example, according to the available data, as of December 2023, 761 hospital admissions worth USD 1.3 million (INR 1.12 crores) were approved for transgender participants under the Pradhan Mantri Jan Aarogya Yojana (PM-JAY). Furthermore, the National Health Authority (NHA) and the Ministry of Social Justice and Empowerment (MoSJE) signed a Memorandum of Understanding (MoU) to extend the benefits of the Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana (AB PM-JAY) for the transgender population.

Increasing Dominance of Male to Female Surgery Segment

Over the course of the forecast period, the male-to-female segment is anticipated to grow at the fastest rate. It is linked to improvements in surgical methods, increased social acceptance, and easier access to healthcare services for those who identify as transgender. Advancements in technology have resulted in safer and more efficient operations, giving confidence to individuals that are pursuing male-to-female transition surgeries. Furthermore, a more welcoming atmosphere in the healthcare industry has been promoted by growing understanding and acceptance of transgender people. The segment's rise has also been aided by increased financial accessibility and wider insurance coverage, which have made these operations more affordable. Due to this, the male-to-female market for sex reassignment surgery is growing and becoming an increasingly important part of the industry. The market is expanding due to government agencies' support and funding. For example, the Ministry of Health, New Zealand, stated in March 2022 that a gender-affirming (genital) surgery service was developed to assist more transgender individuals in obtaining publicly funded gender-affirming genital surgery in New Zealand. The program received USD 2.99 million over four years from Budget 2019 to augment the cash allotted from the High-Cost Treatment Pool for genital operations that promote gender equality. It was anticipated that this financing would allow up to 14 procedures to be performed annually. Such backing from various government organizations is accelerating the market's expansion.

North America to Dominate the Sex Reassignment Surgery Market

Over the course of the projected period, North America is expected to contribute 50% of the growth of the global market. The regional patterns and factors that will shape the market throughout the projection period have been thoroughly studied. Countries such as the United States and Canada have a strong network of specialized clinics and a modern healthcare infrastructure. The availability of skilled surgeons and extensive health insurance also contribute to the market's expansion. The transgender services (SRS) market in North America is dynamic and progressive due to ongoing improvements and a growing understanding of the needs of transgender patients. This ensures that transgender people may receive high-quality treatment that is consistent with their identities. Furthermore, during the projection period, the growing number of individuals choosing to undergo gender reassignment surgery and the rising prevalence of gender dysphoria are anticipated to propel market expansion in the region.

For example, according to a Gallup study, the percentage of American adults who identify as non-heterosexual has more than doubled since 2012. Young people are leading the way, with Generation Z and older adults having approximately twice the likelihood of identifying as LGBTQ+ as their predecessors. According to the survey, approximately 7.6% of adult Americans now identify as lesbian, gay, bisexual, transgender, queer, or as something other than heterosexual. This contrasts with 3.5% in 2012-the year the national polling organization started tracking transgender identity and sexual orientation-and 5.6% four years prior. Various insurance companies cover required surgical operations like ovariectomy, hysterectomy, orchiectomy, and bilateral salpingo-oophorectomy. Thus, during the projection period, the expanding reimbursement environment is anticipated to have a favorable effect on the regional market's growth.

Future Market Scenario (2024-2031F)

The main factors contributing to the anticipated growth of the sex reassignment surgery market is the increasing prevalence of people coming out with an acceptance of their identities. Not only this, but the increasing access to healthcare that includes and gives importance to surgeries and procedures that can alter someone's identity is a factor that will always propel the market growth in the future. Given that technology is advancing, the introduction of advanced technologies in the market is also expected in the forecast period. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. Government policies and policies made by welfare bodies are also greatly fueling the market expansion.

For instance, a guideline on the health of transgender and gender-varied persons is being developed by the WHO's Departments of Gender, Rights and Equity - Diversity, Equity and Inclusion (GRE-DEI), Global HIV, Hepatitis and Sexually Transmitted Infections Programmes (HHS), and Sexual and Reproductive Health and Research (SRH). This new guideline offers evidence-based recommendations and implementation guidelines for health sector initiatives targeted at improving transgender and gender variant people's access to and use of respectful, high-quality healthcare services. The five areas of concentration for the guidelines are provision of gender-affirming care, including hormones; health workers' education and training for the provision of gender-inclusive care; provision of health care for trans and gender diverse people who suffered interpersonal violence based on their needs; health policies that support gender-inclusive care, and legal recognition of self-determined gender identity.

Key Players Landscape and Outlook

Several companies such as Cedars-Sinai Medical Center, Cleveland Clinic, Icahn School of Medicine at Mount Sinai, Moein Surgical Arts, Transgender Surgery Institute, Plastic Surgery Group of Rochester, Regents of the University of Michigan, CNY Cosmetic & Reconstructive Surgery, Boston Medical Center, Johns Hopkins University, etc., are expanding business by planning and adopting new strategies.

GenderGP PTE Ltd., a UK-based telemedicine company that offers hormone therapy and other transgender health services, was acquired by TransHealth, a provider of SRS and other transgender health services, in January 2023.

The Gender Care Centre, a Massachusetts provider of SRS and other transgender health services, was acquired by The Fenway Institute, a research and healthcare organization with headquarters in Boston, in March 2023.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Sex Reassignment Surgery Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. By Gender Transition
  • 4.2.1. Male to Female
  • 4.2.2. Female to Male
• 4.3. By Surgery Type
  • 4.3.1. Face Feminization
  • 4.3.2. Breast Augmentation
  • 4.3.3. Body Contouring
  • 4.3.4. Vaginoplasty
  • 4.3.5. Phalloplasty
  • 4.3.6. Metoidioplasty
  • 4.3.7. Others
• 4.4. By Region
  • 4.4.1. North America
  • 4.4.2. Europe
  • 4.4.3. Asia-Pacific
  • 4.4.4. South America
  • 4.4.5. Middle East and Africa
• 4.5. By Company Market Share (%), 2023

5. Global Sex Reassignment Surgery Market Outlook, By Region, 2017-2031F

• 5.1. North America*
  • 5.1.1. Market Size & Forecast
    • 5.1.1.1. By Value
  • 5.1.2. By Gender Transition
    • 5.1.2.1. Male to Female
    • 5.1.2.2. Female to Male
  • 5.1.3. By Surgery Type
    • 5.1.3.1. Face Feminization
    • 5.1.3.2. Breast Augmentation
    • 5.1.3.3. Body Contouring
    • 5.1.3.4. Vaginoplasty
    • 5.1.3.5. Phalloplasty
    • 5.1.3.6. Metoidioplasty
    • 5.1.3.7. Others
  • 5.1.4. United States*
    • 5.1.4.1. Market Size & Forecast
      • 5.1.4.1.1. By Value
    • 5.1.4.2. By Gender Transition
      • 5.1.4.2.1. Male to Female
      • 5.1.4.2.2. Female to Male
    • 5.1.4.3. By Surgery Type
      • 5.1.4.3.1. Face Feminization
      • 5.1.4.3.2. Breast Augmentation
      • 5.1.4.3.3. Body Contouring
      • 5.1.4.3.4. Vaginoplasty
      • 5.1.4.3.5. Phalloplasty
      • 5.1.4.3.6. Metoidioplasty
      • 5.1.4.3.7. Others
  • 5.1.5. Canada
  • 5.1.6. Mexico

All segments will be provided for all regions and countries covered

• 5.2. Europe
  • 5.2.1. Germany
  • 5.2.2. France
  • 5.2.3. Italy
  • 5.2.4. United Kingdom
  • 5.2.5. Russia
  • 5.2.6. Netherlands
  • 5.2.7. Spain
  • 5.2.8. Turkey
  • 5.2.9. Poland
• 5.3. Asia-Pacific
  • 5.3.1. India
  • 5.3.2. China
  • 5.3.3. Japan
  • 5.3.4. Australia
  • 5.3.5. Vietnam
  • 5.3.6. South Korea
  • 5.3.7. Indonesia
  • 5.3.8. Philippines
• 5.4. South America
  • 5.4.1. Brazil
  • 5.4.2. Argentina
• 5.5. Middle East and Africa
  • 5.5.1. Saudi Arabia
  • 5.5.2. UAE
  • 5.5.3. South Africa

6. Market Mapping, 2023

• 6.1. By Gender Transition
• 6.2. By Surgery Type
• 6.3. By Region

7. Macro Environment and Industry Structure

• 7.1. Demand Supply Analysis
• 7.2. Value Chain Analysis
• 7.3. PESTEL Analysis
  • 7.3.1. Political Factors
  • 7.3.2. Economic System
  • 7.3.3. Social Implications
  • 7.3.4. Technological Advancements
  • 7.3.5. Environmental Impacts
  • 7.3.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.4. Porter's Five Forces Analysis
  • 7.4.1. Supplier Power
  • 7.4.2. Buyer Power
  • 7.4.3. Substitution Threat
  • 7.4.4. Threat From New Entrant
  • 7.4.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 9.1. Clinical Trials
• 9.2. Regulatory Approvals
• 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Case Studies

12. Key Players Outlook

• 12.1. Cedars-Sinai Medical Center
  • 12.1.1. Company Details
  • 12.1.2. Key Management Personnel
  • 12.1.3. Products and Services
  • 12.1.4. Financials (As Reported)
  • 12.1.5. Key Market Focus and Geographical Presence
• 12.2. Cleveland Clinic
• 12.3. Icahn School of Medicine at Mount Sinai
• 12.4. Moein Surgical Arts
• 12.5. Transgender Surgery Institute
• 12.6. Plastic Surgery Group of Rochester
• 12.7. Regents of the University of Michigan
• 12.8. CNY Cosmetic & Reconstructive Surgery
• 12.9. Boston Medical Center
• 12.10. Johns Hopkins University

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

13. Strategic Recommendations

14. About Us & Disclaimer